The goal of this study is to determine whether administering Gabapentin prior to surgery
affects duration of pain and opioid use post-surgery. The investigators aim to compare
gabapentin to placebo in a prospective, randomized clinical trial in which patients will be
followed post-surgery until pain resolves and opioid use ceases.
A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response
Completed
University of Tennessee Health Science Center
N/A
2012-08-01
The Specific aims of this project are to (1) test the prediction that pain from tampon
insertion (primary outcome measure) is lower in PVD patients when treated with gabapentin
compared to when treated with placebo. Secondary outcome measures include intercourse pain
and 24-hour pain and (2)perform a mechanism-based analysis of gabapentin effectiveness, and
to gain insight into the underlying pathophysiology of subtypes of PVD that may lead to more
specific treatment options.
A Trial of Gabapentin in Vulvodynia: Biological Correlates of Response
Completed
University of Tennessee
N/A
2012-08-01
The Specific aims of this project are to (1) test the prediction that pain from tampon
insertion (primary outcome measure) is lower in PVD patients when treated with gabapentin
compared to when treated with placebo. Secondary outcome measures include intercourse pain
and 24-hour pain and (2)perform a mechanism-based analysis of gabapentin effectiveness, and
to gain insight into the underlying pathophysiology of subtypes of PVD that may lead to more
specific treatment options.
Quality of Life Study Using Gabapentin Versus Venlafaxine in Treating Hot Flashes in Patients With Prostate Cancer
Terminated
University of Wisconsin, Madison
Phase 2
2012-02-01
The purpose of this study is to assess the change in quality of life over a 6 month period
between gabapentin and venlafaxine in men with prostate cancer treated for hot flashes
related to androgen deprivation therapy.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
